Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Stereotaxis, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DC
DAFNA Capital Management LLC
13D · 15.1%
|
13.7M | 13.34% | Unchanged | ≤2021 | 4.5% | |
|
Shares held by quarter
Peak holding13.7M (Q3'24)
Change over 8 quarters0
Share of the company13.340%
Disclosed stake13D · 15.1%
|
||||||
|
B
BlackRock, Inc.
|
4.4M | 4.29% | +440.6K (+11.1%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding4.4M (Q2'26)
Change over 8 quarters+571.3K
Share of the company4.290%
|
||||||
28 more super investors behind a free account
See every manager holding Stereotaxis, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$3.41M | 2.0M | 1.93% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$2.81M | 1.6M | 1.59% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Stereotaxis, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DN
Dr. Nathan Fischel
5%+ holder
13D · 15.3%
|
15.6M | 15.24% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
DF
Dr. Fariba Ghodsian
5%+ holder
13D · 15.1%
|
15.3M | 14.95% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
6 more holders behind a free account
See every insider and 5%+ holder of Stereotaxis, Inc..
Sign up freeLoading...